Label: BLISS REPUBLIC DARK SPOT WAND- dark spot wand solution

  • NDC Code(s): 84028-112-11, 84028-112-12
  • Packager: Sargass Group Limited Liability Company
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 16, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient(s)

    Niacinamide 2%................. Reduce Dark Spots

  • Purpose

    Reduce Dark Spots

  • Use

    To reduce Dark Spots on the skin

  • Warnings

    For external use only

  • WHEN USING

    Avoid contact with eyes.

  • KEEP OUT OF REACH OF CHILDREN

    Keep away from children. Avoid contact with eyes. In case of accidental ingestion, seek medical attention immefiately.

  • STOP USE

    Discontinue use if no improvement is seen after 3 months of treatment.

  • Directions

    Age: 18+ Use once a day (morning or

    evening) to well-cleansed skin

    Apply sparingly and directly

    to dark spots.

  • Other information

    Always wear daily sunscreen of SPF 15 or higher when used on very dark skin.

    The lighting effect of this product may not be noticeable.

    Limit sun exposure to prevent reoccurrence of darkening.

  • Inactive ingredients

    Water, Glycerin, Isobutane, Erythritol, Angelica keiskei extract, Hydrolyzed

    collagen, Phloretin, Stephania tetrandra extract, Paeonia veitchii root extract, Propane, Carbomer, Dimethyl ether, Taraxacum officinale

    (dandelion) leaf extract, 3-0-Ethyl ascorbic acid, Saururus chinensis extract,

    Hyaluronic acid, Phenoxyethanol, Ethylhexylglycerin, Tranexamic acid,

    Turmeric root extract, Kojic acid, Salicylic acid, Floral Scent.

  • Package Label - Principal Display Panel

    Darkspot-1530mL NDC: 84028-112-11

  • INGREDIENTS AND APPEARANCE
    BLISS REPUBLIC DARK SPOT WAND 
    dark spot wand solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84028-112
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE2 mg  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    PROPANE (UNII: T75W9911L6)  
    TURMERIC (UNII: 856YO1Z64F)  
    3-O-ETHYL ASCORBIC ACID (UNII: 6MW60CB71P)  
    PAEONIA VEITCHII ROOT (UNII: VX6GD6M93V)  
    PHLORETIN (UNII: S5J5OE47MK)  
    STEPHANIA TETRANDRA ROOT (UNII: 48PS81XHK0)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    TRANEXAMIC ACID (UNII: 6T84R30KC1)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    ISOBUTANE (UNII: BXR49TP611)  
    ANGELICA KEISKEI ROOT (UNII: 4LA4RT8O6P)  
    SAURURUS CHINENSIS FLOWER (UNII: 9L0SCP0SKZ)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    KOJIC ACID (UNII: 6K23F1TT52)  
    DIMETHYL ETHER (UNII: AM13FS69BX)  
    TARAXACUM OFFICINALE LEAF (UNII: 0022LFJ74Y)  
    SALICYLIC ACID (UNII: O414PZ4LPZ)  
    HYALURONIC ACID (UNII: S270N0TRQY)  
    HYDROLYSED MARINE COLLAGEN (ENZYMATIC; 2000 MW) (UNII: 2WID9OCG7P)  
    ERYTHRITOL (UNII: RA96B954X6)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84028-112-1115 mL in 1 BOTTLE; Type 0: Not a Combination Product01/03/2024
    2NDC:84028-112-1230 mL in 1 BOTTLE; Type 0: Not a Combination Product01/03/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01601/03/2024
    Labeler - Sargass Group Limited Liability Company (119155798)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!